MHRA
- Local brand name: Heparesc
- Status: approved
Human Heterologous Liver Cells (Human Heterologous Liver Cells) regulatory status in United Kingdom.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA has authorised it.
Cytonet GmbH & Co. KG is the originator. The local marketing authorisation holder may differ — check the official source linked above.